FOXM1 overexpression is associated with adverse outcome and predicts response to intravesical instillation therapy in stage pT1 non-muscle-invasive bladder cancer

Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends

(2017) Sebastien Antoni et al.   EUROPEAN UROLOGY

EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016

(2017) Marko Babjuk et al.   EUROPEAN UROLOGY

In stage pT1 non-muscle-invasive bladder cancer (NMIBC), high KRT20 and low KRT5 mRNA expression identify the luminal subtype and predict recurrence and survival

(2017) Johannes Breyer et al.   VIRCHOWS ARCHIV

FOXM1 predicts overall and disease specific survival in muscle-invasive urothelial carcinoma and presents a differential expression between bladder cancer subtypes

(2017) Sebastien Rinaldetti et al.   Oncotarget

Technical validation of an RT-qPCR in vitro diagnostic test system for the determination of breast cancer molecular subtypes by quantification of ERBB2, ESR1, PGR and MKI67 mRNA levels from formalin-fixed paraffin-embedded breast tumor specimens

(2016) Mark Laible et al.   BMC CANCER

Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma

(2016) Jakob Hedegaard et al.   CANCER CELL

Expression of FOXM1 and related proteins in breast cancer molecular subtypes

(2016) Jeong-Ju Lee et al.   INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY

Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Guideline

(2016) Sam S. Chang et al.   JOURNAL OF UROLOGY

Low adherence to guidelines in non-muscle-invasive disease

(2016) Bas W. G. van Rhijn et al.   Nature Reviews Urology

Development and Validation of a Novel Recurrence Risk Stratification for Initial Non-muscle Invasive Bladder Cancer in Asia

(2016) Takeshi Ieda et al.   EBioMedicine

Molecular subtypes of urothelial carcinoma are defined by specific gene regulatory systems

(2015) Pontus Eriksson et al.   BMC Medical Genomics

Prognostic Value of FOXM1 in Patients with Malignant Solid Tumor: A Meta-Analysis and System Review

(2015) Jun Dai et al.   DISEASE MARKERS

A Molecular Pathologic Framework for Risk Stratification of Stage T1 Urothelial Carcinoma

(2015) Oliver Patschan et al.   EUROPEAN UROLOGY

Prediction of 90-day Mortality After Radical Cystectomy for Bladder Cancer in a Prospective European Multicenter Cohort

(2014) Atiqullah Aziz et al.   EUROPEAN UROLOGY

Tumour-suppressivemicroRNA-24-1inhibits cancer cell proliferation through targetingFOXM1in bladder cancer

(2014) Satoru Inoguchi et al.   FEBS LETTERS

Forkhead box transcription factor 1 expression in gastric cancer: FOXM1 is a poor prognostic factor and mediates resistance to docetaxel

(2013) Xiaoxiao Li et al.   Journal of Translational Medicine

High FOXM1 expression was associated with bladder carcinogenesis

(2013) Dongye Liu et al.   TUMOR BIOLOGY

A Molecular Taxonomy for Urothelial Carcinoma

(2012) G. Sjodahl et al.   CLINICAL CANCER RESEARCH

Multiple faces of FoxM1 transcription factor

(2011) Tanya V. Kalin et al.   CELL CYCLE

A New Molecular Predictor of Distant Recurrence in ER-Positive, HER2-Negative Breast Cancer Adds Independent Information to Conventional Clinical Risk Factors

(2011) Martin Filipits et al.   CLINICAL CANCER RESEARCH

Over-expression of FoxM1 leads to epithelial-mesenchymal transition and cancer stem cell phenotype in pancreatic cancer cells

(2011) Bin Bao et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

FoxM1 Mediates Resistance to Herceptin and Paclitaxel

(2010) Janai R. Carr et al.   CANCER RESEARCH

p53 negatively regulates expression of FoxM1

(2010) Bulbul Pandit et al.   CELL CYCLE

FOXM1 Confers Acquired Cisplatin Resistance in Breast Cancer Cells

(2010) J. M.-M. Kwok et al.   MOLECULAR CANCER RESEARCH

FoxM1B Transcriptionally Regulates Vascular Endothelial Growth Factor Expression and Promotes the Angiogenesis and Growth of Glioma Cells

(2008) Yujian Zhang et al.   CANCER RESEARCH

Early Versus Deferred Cystectomy for Initial High-Risk pT1G3 Urothelial Carcinoma of the Bladder: Do Risk Factors Define Feasibility of Bladder-Sparing Approach?

(2007) Stefan Denzinger et al.   EUROPEAN UROLOGY